And, herein lies the issue with $NVDA gorgeous ER, Phenomenal ER. I mean does it get much better than this?
✅Beat on Revenue $96.2B
✅Beat on EPS $2.22
✅Q3 Guidance
Over 106% Year on year revenue growth and what happens? Sells off. Luckily it got bought back up but for